Facile entry to (-)-(R)- and (+)-(S)-mexiletine

Chirality

Volumn 12, Issue 3, 2000, Pages 103-106

  Carocci, Alessia ^a   Franchini, Carlo ^a   Lentini, Giovanni ^a   Loiodice, Fulvio ^a   Tortorella, Vincenzo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

Antiarrhythmic drug; Chiral HPLC analysis; Enantiomeric excess; Regiospecific S(N)2 epoxide ring opening; Stereospecific synthesis

Indexed keywords

ANTIARRHYTHMIC AGENT; MEXILETINE;

ANTIARRHYTHMIC ACTIVITY; ARTICLE; CHEMICAL STRUCTURE; CHIRALITY; DRUG STRUCTURE; DRUG SYNTHESIS; ENANTIOMER; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; PRIORITY JOURNAL; STEREOCHEMISTRY;

ANTI-ARRHYTHMIA AGENTS; MEXILETINE; STEREOISOMERISM;

EID: 0034100219     PISSN: 08990042     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1520-636X(2000)12:3<103::AID-CHIR1>3.0.CO;2-X     Document Type: Article

References (23)

1. Turgeon J, Uprichard ACG, Bélanger PM, Harron DWG, Grech-Bélanger O. Resolution and electrophysiological effects of mexiletine enantiomers. J Pharm Pharmacol 1991;43:630-635.
2. Hill RJ, Duff HJ, Sheldon RS. Determinants of stereospecific binding of type I antiarrhythmic drugs to cardiac sodium channels. Mol Pharmacol 1988;34:659-663.
3. De Luca A, Natuzzi F, Lentini G, Franchini C, Tortorella V, Conte Camerino D. Stereoselective effects of mexiletine enantiomers on sodium currents and excitability characteristics of adult skeletal muscle fibers. Naunyn Schmiedebergs Arch Pharmacol 1995;352:653-661.
4. De Luca A, Natuzzi F, Falcone G, Duranti A, Lentini G, Franchini C, Tortorella V, Conte Camerino D. Inhibition of frog skeletal muscle sodium channels by newly synthesized chiral derivatives of mexiletine and tocainide. Naunyn Schmiedebergs Arch Pharmacol 1997;356:777-787.
5. Clarke DE, Lyles GA, Calligham BA. A comparison of cardiac and vascular clorgyline-resistant amine oxidase and monoamine oxidase. Biochem Pharmacol 1982;31:27-35.
6. Zeitlin AL. Methods for treating central and peripheral nerve pain. U.S. Patent 97,7867,49, 1999. Chem Abstr 1999;129:153250.
7. Grech-Bélanger O, Turgeon J, Gilbert M. High-performance liquid chromatographic assay for mexiletine enantiomers in human plasma. J Chromatogr 1985;337:172-177.
8. McErlane KM, Igwemezie L, Kerr CR. Stereoselective analysis of the enantiomers of mexiletine by high-performance liquid chromatography using fluorescence detection and study of their stereoselective disposition in man. J Chromatogr 1987;415:335-346.
9. Igwemezie L, Kerr CR, McErlane KM. The pharmacokinetics of the enantiomers of mexiletine in humans. Xenobiotica 1989;19:677-682.
10. Lanchote VL, Cesarino EJ, Santos VJ, Moraes-Júnior AV, Zanardi AMT, Santos SRCJ. Stereoselective metabolism of mexiletine in chagasic women with chronic ventricular arrhythmias. Eur J Drug Metab Pharmacokinet, Special issue: 1996:71.
11. Knoche B, Gehrcke B, König WA, Wainer IW. Determination of the enantiomeric composition of mexiletine and its four hydroxylated metabolites in urine by enantioselective capillary gas chromatography. Chirality 1996;8:30-34.
12. Lanchote VL, Bonato PS, Cesarino EJ, Mere YA Jr, Santos SRCJ, Bertucci C. Enantioselective determination of the hydroxylated metabolites of mexiletine in human plasma. Chirality 1997;9:732-738.
13. Lanchote VL, Cesarino EJ, Santos VJ, Mere Y Jr, Santos SRCJ. Enantioselectivity in the metabolism of mexiletine by conjugation in female patients with the antiarrhythmic form of chronic Chagas' heart disease. Chirality 1999;11:29-32.
14. Turgeon J, Paré JRJ, Lalande M, Grech-Bélanger O, Bélanger PM. Isolation and structural characterization by spectroscopic methods of two glucuronide metabolites of mexiletine after N-oxidation and deamination. Drug Metab Dispos 1992;20:762-769.
15. Igwemezie L, Beatch GN, Walker MJA, McErlane KM. Tissue distribution of mexiletine enantiomers in rats. Xenobiotica 1991;21:1153-1158.
16. Franchini C, Cellucci C, Corbo F, Lentini G, Scilimati A, Tortorella V, Stasi F. Stereospecific synthesis and absolute configuration of mexiletine. Chirality 1994;6:590-595.
17. Aav R, Parve O, Tõnis P, Claesson A, Martin I. Preparation of highly enantiopure stereoisomers of 1-(2,6-dimethylphenoxy)-1-aminopropane (mexiletine). Tetrahedron: Asymmetry 1999;10:3033-3038.
18. Phillips GT, Shears JH. Method for stereoselective preparation of enantiomers of 1-(2,6-dimethylphenoxy)-2-aminopropane (mexiletine) and its N-acyl derivatives. U.K. Patent GB 2246774, 1992. Chem Abstr 1992;116:254070s.
19. 3-complexed aromatic fluoride. J Org Chem 1999;64:3373-3375.
20. Hamilton J, Mahaffy AAL. The preparation of aryl alkyl ethers from fluoroarenetricarbonylchromium complexes. Synth React Inorg Met Org Chem 1986;16:1363-1369.
21. De Luca A, Pierno S, Natuzzi F, Franchini C, Duranti A, Lentini G, Tortorella V. Evaluation of the antimyotonic activity of mexiletine and some new analogs on sodium currents of single muscle fibers and on the abnormal excitability of the myotonic ADR mouse. J Pharmacol Exp Ther 1997;282:93-100.
22. Mitsunobu O. The use of diethyl azodicarboxylate and triphenylphosphine in synthesis and transformation of natural products. Synthesis 1981:1-28.
23. Duranti A, Franchini C, Lentini G, Sinicropi MS. Contribution to the study of 2-aryloxy-1-phenyl- and 2-aryloxy-2-phenylethanols. Differentiation by mass spectrometry. J Mass Spectrom 1998;33:486-487.